Genotype-phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene

被引:21
作者
I. Kato
J. Eastham
B. Li
M. Smith
H. Yu
机构
[1] Karmanos Cancer Institute, Department of Pathology, Wayne State University, Detroit, MI
[2] Section of Cancer Prevention, Feist-Weiller Cancer Center, Louisiana Stt. Univ. Hlth. Sci. Ctr., Shreveport, LA
[3] Section of Urologic Oncology, Feist-Weiller Cancer Center, Louisiana Stt. Univ. Hlth. Sci. Ctr., Shreveport, LA
[4] Department of Urology, Mem. Sloan Kettering Cancer Center, New York, NY
[5] Section of Surgical Oncology, Feist-Weiller Cancer Center, Louisiana Stt. Univ. Hlth. Sci. Ctr., Shreveport, LA
[6] Department of Epidemiology, Yale University School of Medicine, New Haven, CT
[7] Department of Epidemiology, Karmanos Cancer Institute, Detroit, MI 48201
基金
美国国家卫生研究院;
关键词
Genetic polymorphism; Insulin-like growth factor-I; Microsatellite repeats;
D O I
10.1023/A:1023379100539
中图分类号
学科分类号
摘要
Polymorphic microsatellite dinucleotide (cytosine-adenine, CA) repeats of the insulin-like growth factor-I (IGF-I) gene may have implications in the development of certain types of cancer and osteoporosis. We studied correlations between IGF-I genotypes determined by direct sequencing and plasma IGF-I levels among 113 healthy individuals (60 men and 53 women), who were originally enrolled as controls for hospital-based case-control studies of breast and prostate cancer. On the contrary to an earlier observation, there were no differences in plasma IGF-I levels between those with and without the allele of 19 repeats. With adjustment for other confounders, there were no trends in plasma IGF-I levels with increasing or decreasing the number of CA repeats among all study subjects combined, all Whites or all Blacks, suggesting no overall functional significance of this polymorphism. Opposite trends observed in gender and racial subgroups, i.e., an inverse association between plasma IGF-I levels and the CA repeat length in white women and a positive association in black men, are likely to be chance findings.
引用
收藏
页码:203 / 209
页数:6
相关论文
共 43 条
[1]  
Bruning P.F., Van Doorn J., Bonfrer J.M., Et al., Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer, Int J Cancer, 62, pp. 266-270, (1995)
[2]  
Hankinson S.E., Willett W.C., Colditz G.A., Et al., Circulating concentrations of insulin-like growth factor-I and risk of breast cancer, Lancet, 351, pp. 1393-1396, (1998)
[3]  
Chan J.M., Stampfer M.J., Giovannucci E., Et al., Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study, Science, 279, pp. 563-566, (1998)
[4]  
Wolk A., Mantzoros C.S., Andersson S.O., Et al., Insulinlike growth factor 1 and prostate cancer risk: A population-based, case-control study, J Natl Cancer Inst, 90, pp. 911-915, (1998)
[5]  
Manousos O., Souglakos J., Bosetti C., Et al., IGF-I and IGF-II in relation to colorectal cancer, Int J Cancer, 83, pp. 15-17, (1999)
[6]  
Ma J., Pollak M.N., Giovannucci E., Et al., Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3, J Natl Cancer Inst, 91, pp. 620-625, (1999)
[7]  
Giovannucci E., Pollak M.N., Platz E.A., Et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal cancer in women, Cancer Epidemiol Biomarkers Prev, 9, pp. 345-349, (2000)
[8]  
Yu H., Spitz M.R., Mistry J., Gu J., Hong W.K., Wu X., Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis, J Natl Cancer Inst, 91, pp. 151-156, (1999)
[9]  
Cohen P., Clemmons D.R., Rosenfeld R.G., Does the GH-IGF axis play a role in cancer pathogenesis?, Growth Horm IGF Res, 10, pp. 297-305, (2000)
[10]  
Rosen C.J., Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications, Clin Chem, 45, pp. 1384-1390, (1999)